Buzzing Stocks: Infosys, M&M, Sun Pharma and others that will be in focus today
Follow our LIVE blog for the latest updates on the novel coronavirus pandemic and its impact
Indian markets are likely to see a gap up opening tracking strong global cues amid falling Covid-19 cases and more fiscal stimulus expected to support the economy. However, global news flows and sector specific development will be key monitorables. US markets ended mixed amid release of macroeconomic data.
Petrol, diesel prices Update:
Petrol and diesel prices remained unchanged on May 28 across the country after a hike in prices on the previous day. Price of petrol in Delhi was at Rs 93.68 per litre while that of diesel was Rs 84.61 per litre.
Petrol price in Mumbai also remained unchanged at Rs 99.94 per litre, while the price of diesel was Rs 91.87 in the financial capital, according to Indian Oil Corporation (IOC).
Market at pre-open: Benchmark indices are trading higher in the pre-opening session amid positive global cues.
At 09:02 IST, the Sensex was up 194.95 points or 0.38% at 51310.17, and the Nifty was up 39.80 points or 0.26% at 15377.70.
Gold prices were flat on Friday, as an uptick in the dollar and US Treasury yields pressured bullion, while investors awaited crucial US inflation data later in the day.
Trade Spotlight: What Should Investors Do With Jai Corp, MindTree & Sonata Software?
Here’s what Shrikant Chouhan of Kotak Securities recommends investors should do with these stocks when the market resumes trading today:
FII and DII data
Foreign institutional investors (FIIs) net sold shares worth Rs 660.90 crore, while domestic institutional investors (DIIs) net bought shares worth Rs 112.38 crore in the Indian equity market on May 27, as per provisional data available on the NSE.
Results on May 28
Mahindra & Mahindra, Glenmark Pharmaceuticals, Indian Bank, Ipca Laboratories, 3M India, Aditya Birla Fashion and Retail, Action Construction Equipment, Ador Multiproducts, Ador Welding, Arvind SmartSpaces, Aurionpro Solutions, Bengal & Assam Company, Camlin Fine Sciences, Confidence Petroleum India, Dilip Buildcon, Deepak Fertilisers & Petrochemicals Corporation, Prataap Snacks, Force Motors, Genus Power Infrastructures, GMM Pfaudler, Gulf Oil Lubricants India, Heidelbergcement India, ITD Cementation India, Jagran Prakashan, Jindal Poly Films, Max Healthcare Institute, Munoth Financial Services, Navkar Corporation, Nazara Technologies, NCC, NESCO, OnMobile Global, Shree Rama Newsprint, REC, Reliance Infrastructure, SMS Pharmaceuticals, Sudarshan Chemical Industries, Sumitomo Chemical India, Ujjivan Financial Services, V-Mart Retail, and Zuari Agro Chemicals.
Sun Pharmaceutical Industries Q4:
Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit to Rs 894.15 crore for the quarter ended March 2021, mainly on account of robust performance in the Indian market.
The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
Consolidated total revenue from operations stood at Rs 8,522.98 crore for the quarter under consideration. It was Rs 8,184.94 crore in the same period a year ago, it added.
Hot Stocks | BSE, Infosys, Asian Paints Can Give 13-31% Returns In Short Term
The key support levels to watch out for in the short-term are 15,135 (previous swing high) and 14,884 (5-day low).
Asian stocks extend global rally to 7th day, US stimulus in focus
Asian stocks put global equities on course for a seventh day of gains on Friday as investors bet the U.S. will lead the world out of the COVID-19 pandemic, with the focus turning to a multi-trillion dollar spending boost by the Biden administration.